Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03890861 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

Study acronym: RAATE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 25, 2024 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Nov 2025 to Nov 2026v9
  2. Primary completion date: Jun 2025 to Nov 2025
    • Study completion date: Nov 30, 2026 to Nov 2025
    • Site contact updated
    v8
  3. Enrollment target: 200 to 125v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary completion date: Feb 2023 to Jun 2025
    • Study completion date: Nov 30, 2023 to Nov 30, 2026
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Feb 2022 to Feb 2023
    • Eligibility criteria shortened, about 12 words
    • Study description expanded, about 411 words
    v4
  2. Trial status: Suspended to Recruiting
    • Site details revised
    v3
  3. Trial status: Not Yet Recruiting to Suspended Sponsor's reason: Temporarily paused due to COVID-19 and expected to resume.
    • Start date changed from estimate of Aug 2019 to Aug 9, 2019
    • Site contact updated
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The RAATE proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. There are three main objectives of the protocol: 1) to determine if a physical activity intervention tailored to older African American adults is effective in modifying cognitive function associated with Alzheimer's Disease, 2) to determine if a physical activity intervention tailored to older African American adults is effective in modifying brain function and structure associated with Alzheimer's Disease, and 3) to determine if a physical activity promotion intervention tailored to African American adults is effective at enhancing physiological parameters. The primary endpoints for the study are episodic memory and executive functioning. The secondary outcomes include anthropometry, blood pressure, brain activation, cerebral blood flow, volume of whole brain and white matter hyperintensities, cardiorespiratory fitness, objectively measured physical activity, circulating hormones, and telomere length.
Trial Details
NCT Number NCT03890861
Lead Sponsor Pennington Biomedical Research Center
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Dementia, Alzheimer Type
Related terms Alzheimer Disease, Motor Activity
Enrollment 125 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov